Observational studyVirology journal2025
Burden and characteristics of Respiratory Syncytial Virus-associated respiratory tract infections in adult patients in the winter season 2023/2024 at the conservative emergency department of the university hospital in Dresden.
Observational study in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe burden of Respiratory Syncytial Virus (RSV) associated adult emergency department visits in comparison to other respiratory viruses like Influenza and SARS-CoV-2 remains less studied.
methodsWe performed a prospective observational study to describe prevalence, severity and risk factors of RSV infection, proven by polymerase chain reaction from nasopharyngeal or pharyngeal swabs, in consecutive adult patients presenting to the emergency ward of the University Hospital Dresden with a working diagnosis of acute respiratory tract infection during the winter season between October 1st 2023 and April 15th 2024.
results1764 adults (56.3% male) between 18 and 101 years old (median age 69 years) were included in the analysis. 477 patients (27.1%) tested positive for viral infection; 284 (16.2%) with SARS-CoV-2 (median age 79 years), 147 (8.4%) with Influenza A or B (median age 56 years) and 38 (2.2%) with RSV A or B (median age 79 years). In 8 patients (0.5%) a co-infection with two viruses was detected. In the RSV cohort any oxygen support was significantly higher (63.2%) compared to the Influenza (34.0%, p < 0.001) and SARS-CoV-2 (41.5%, p = 0.012) cohorts. In-hospital mortality was considerable especially for RSV with 7.9% compared to Influenza (2.7%, p = 0.138) and SARS-CoV-2 (5.6%, p = 0.580).
conclusionRSV was less frequent in adults presenting to the emergency department during the 2023/24 season compared to SARS-CoV-2 and Influenza, but patients needed a higher level of respiratory support. Also, in-hospital mortality was considerable, making RSV-infections a relevant pathogen in adult patients presenting with respiratory tract infection to an emergency department.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.